eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironmentDidem Karakaş(Acıbadem University)Cell Death and DiseaseJuly 7, 202510.1038/s41419-025-07803-wCited by 5SaveCiteExport RISWatch citationsRelated PapersTargeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells|Biomedicines|2023|6